Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sino-German trade barriers "must be dismantled" to benefit of medtech

This article was originally published in Clinica

Executive Summary

German medtech industry association Spectaris has demanded that trade barriers with China be broken down. "German interest in the Chinese medtech market is enormous," said the association's deputy chairman, Michael Koller. But for smooth bilateral relations to be maintained, outstanding environmental law issues and product approval sticking-points must be addressed, he told the Deutsch-Chinesische Dialogforum on industrial and technological co-operation, in Berlin. Chinese Premier Wen Jiabao was present at the meeting to hear Mr Koller ask for China to exclude medtech products from its national law on banning certain dangerous substances, and thereby adopt the European-style approach on this issue. He also asked for China to become more involved in the GHTF process, noting the potential benefits of mutual recognition of trials. Germany exports medtech products valued at €500m ($648m) to China and imports some €340m-worth.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT042631

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel